*Short Dated* NexHA (Hyaluronate Sodium) Injectable - Generic Legend
NexHA™ is an injectable solution for treating joint dysfunction in horses, FDA approved as bioequivalent to Legend®. It contains hyaluronate sodium and is administered intravenously.
- NexHA™ is FDA approved as bioequivalent to Legend®
- It is used for treating joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis
- Treatment involves 4 mL injections, repeated up to three times weekly
Variants (1)
- Default Title — 72.99 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
86%